Genervon Biopharmaceuticals, LLC   Report issue

For profit Phase 2
Founded: Pasadena CA United States (1996)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2011
NCT01221246
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now